Luina Benevides Lima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Luina Benevides Lima has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Raquel Carvalho Montenegro
Laboratory of Pharmacogenetics, Drug Research and Development Center (NPDM), Federal University of Ceará, Cel. Nunes de Melo, Fortaleza, Brazil; Red Latinoamericana de Implementación y Validación de guias clinicas Farmacogenomicas (RELIVAF), Brazil
2 shared publications - Acy Telles de Souza Quixadá
Secretaria de Saúde do Estado do Ceará (SESA)
1 shared publication - Allysson Allan de Farias
Universidade Federal do Ceará
1 shared publication - Andre Luiz Campelo dos Santos
Department of Electrical Engineering and Computer Science, Florida Atlantic University , Boca Raton, FL
1 shared publication - Antônio Sílvio Teixeira dos Santos1 shared publication
Beatriz Freire Guimarães
1 shared publication
Latest Publications
- Open Access
- 18 April 2026
- Published by Elsevier in SSRN Electronic Journal
Pre-colonial reoccupied funerary hubs in Northeast Brazil: Multiple occupations and mitochondrial diversity
Northeast Brazil remains one of the least represented regions in the ancient DNA record of South America, despite its rich archaeological heritage and its relevance for understanding indigenous population history. Here, we investigated maternal genetic diversity and patterns of funerary site reuse in the Cariri region through mitochondrial DNA analysis of ancient human teeth recovered from four rock shelter cemeteries in Paraíba, namely Pinturas I, Furna dos Ossos, Serrote dos Ossos, and Toca dos Astros. Twenty-two teeth were processed under ancient DNA decontamination procedures, and mitochondrial hypervariable regions were amplified and sequenced by Sanger technology. After preprocessing, haplogroups were assigned using Haplogrep 3. Of the 21 successfully sequenced specimens, seven yielded identifiable Indigenous American mitochondrial lineages, whereas the remaining samples failed to amplify or showed evidence of exogenous contamination. The mitochondrial sequences belonged to haplogroups A2, C1, D4, and B4, documenting multiple maternal lineages across cemeteries dated from approximately 1140 BP to the late pre-colonial and early colonial periods. Pinturas I showed particularly high diversity, with three distinct haplogroups found among individuals from different burial contexts, supporting the interpretation of these sites as reoccupied funerary hubs rather than single population cemeteries. Comparative analysis with other ancient Brazilian datasets indicates that the Cariri individuals shared the broader Native American maternal ancestry profile observed elsewhere in South America. These findings provide the first mitochondrial evidence for pre-colonial populations from the Cariri backlands and suggest long-term reuse of sacred mortuary spaces by genetically diverse indigenous groups in Northeast Brazil.
- 18 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessPre-colonial reoccupied funerary hubs in Northeast Brazil: Multiple occupations and mitochondrial diversity
Northeast Brazil remains one of the least represented regions in the ancient DNA record of South America, despite its rich archaeological heritage and its relevance for understanding indigenous population history. Here, we investigated maternal genetic diversity and patterns of funerary site reuse in the Cariri region through mitochondrial DNA analysis of ancient human teeth recovered from four rock shelter cemeteries in Paraíba, namely Pinturas I, Furna dos Ossos, Serrote dos Ossos, and Toca dos Astros. Twenty-two teeth were processed under ancient DNA decontamination procedures, and mitochondrial hypervariable regions were amplified and sequenced by Sanger technology. After preprocessing, haplogroups were assigned using Haplogrep 3. Of the 21 successfully sequenced specimens, seven yielded identifiable Indigenous American mitochondrial lineages, whereas the remaining samples failed to amplify or showed evidence of exogenous contamination. The mitochondrial sequences belonged to haplogroups A2, C1, D4, and B4, documenting multiple maternal lineages across cemeteries dated from approximately 1140 BP to the late pre-colonial and early colonial periods. Pinturas I showed particularly high diversity, with three distinct haplogroups found among individuals from different burial contexts, supporting the interpretation of these sites as reoccupied funerary hubs rather than single population cemeteries. Comparative analysis with other ancient Brazilian datasets indicates that the Cariri individuals shared the broader Native American maternal ancestry profile observed elsewhere in South America. These findings provide the first mitochondrial evidence for pre-colonial populations from the Cariri backlands and suggest long-term reuse of sacred mortuary spaces by genetically diverse indigenous groups in Northeast Brazil.
- Open Access
- 1 October 2023
- Published by Department of Chemistry and Biochemistry, Al-Nahrain University in Baghdad Journal of Biochemistry and Applied Biological Sciences
- Vol. 4 (4) , 204-214
The impact of COVID-19 of blood donations and blood components usage in Ceará, Brazil
With increase cases of Coronavirus disease in Brazil and the virus propagation around the world, several health sectors were negatively affected, including hemotherapy services and generating a decrease in blood donation. In this study, we gathered information about total blood donations and usage during COVID-19 pandemic in the state of Ceará, located in the northeast side of Brazil. More specifically data from donations between April 2020 and September 2021 and compared with data gathered from donations of pre-pandemic period. During the period, the state of Ceará received 181.362 candidates for blood donation. Of these, 80.16% were eligible for donation and 19.84% unfit. The number of candidates decreased by 16.72% in 2020 and 5.10% in 2021 in comparison to the same periods in 2018. The main causes of inability for candidates during the pandemic period were low hematocrit/hemoglobin, occasional sexual intercourse in the last 12 months and suspicion or confirmation of COVID in the last 10 days. However, the increasing number of critically ill hospitalized COVID patients increased the blood supply, as transfusions increased by 1.03% in 2020 and 7.96% in 2021, showing a higher demand in RBC, platelets, FFP and CRYO. The pandemic had a significant impact on national blood stocks, causing a change in donation behavior and causing a concern to maintain an adequate blood supply during this crisis. Despite the situation, the stock of blood components in HEMOCE met the Ceará blood demand in the hospitals.
- 1 October 2023
- Published by Department of Chemistry and Biochemistry, Al-Nahrain University in Baghdad Journal of Biochemistry and Applied Biological Sciences
- Vol. 4 (4) , 204-214
Open AccessThe impact of COVID-19 of blood donations and blood components usage in Ceará, Brazil
With increase cases of Coronavirus disease in Brazil and the virus propagation around the world, several health sectors were negatively affected, including hemotherapy services and generating a decrease in blood donation. In this study, we gathered information about total blood donations and usage during COVID-19 pandemic in the state of Ceará, located in the northeast side of Brazil. More specifically data from donations between April 2020 and September 2021 and compared with data gathered from donations of pre-pandemic period. During the period, the state of Ceará received 181.362 candidates for blood donation. Of these, 80.16% were eligible for donation and 19.84% unfit. The number of candidates decreased by 16.72% in 2020 and 5.10% in 2021 in comparison to the same periods in 2018. The main causes of inability for candidates during the pandemic period were low hematocrit/hemoglobin, occasional sexual intercourse in the last 12 months and suspicion or confirmation of COVID in the last 10 days. However, the increasing number of critically ill hospitalized COVID patients increased the blood supply, as transfusions increased by 1.03% in 2020 and 7.96% in 2021, showing a higher demand in RBC, platelets, FFP and CRYO. The pandemic had a significant impact on national blood stocks, causing a change in donation behavior and causing a concern to maintain an adequate blood supply during this crisis. Despite the situation, the stock of blood components in HEMOCE met the Ceará blood demand in the hospitals.
- Open Access
- 11 June 2022
- Published by Publicacoes Cientificas de Acesso Aberto e Editora LTDA in Brazilian Journal of Case Reports
Chronic myeloid leukemia management during pregnancy: a case report
Chronic Myeloid Leukemia (CML) is characterized by the increased and unregulated growth of myeloid cells in bone marrow and accumulation of these cells in blood. Its occurrence during pregnancy is a very rare condition and the correct management is not well stablished yet. We present a case of a 21-year-old female diagnosed with CML during pregnancy. The protocol chose by the doctor was hydroxyurea on second trimester, and interferon-alpha on third trimester. The baby was born healthy and at the expected time. After giving birth, the patient started Imatinib Mesilate (IM) 400mg/day treatment and was able to control the disease.
- 11 June 2022
- Published by Publicacoes Cientificas de Acesso Aberto e Editora LTDA in Brazilian Journal of Case Reports
Open AccessChronic myeloid leukemia management during pregnancy: a case report
Chronic Myeloid Leukemia (CML) is characterized by the increased and unregulated growth of myeloid cells in bone marrow and accumulation of these cells in blood. Its occurrence during pregnancy is a very rare condition and the correct management is not well stablished yet. We present a case of a 21-year-old female diagnosed with CML during pregnancy. The protocol chose by the doctor was hydroxyurea on second trimester, and interferon-alpha on third trimester. The baby was born healthy and at the expected time. After giving birth, the patient started Imatinib Mesilate (IM) 400mg/day treatment and was able to control the disease.